Authors:
Manegold, C
Hannoun, C
Wywiol, A
Dietrich, M
Polywka, S
Chiwakata, CB
Gunther, S
Citation: C. Manegold et al., Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy, CLIN INF D, 32(1), 2001, pp. 144-148
Authors:
Vansteenkiste, J
Gatzemeier, U
Manegold, C
Hanauske, A
Weynants, P
Bosquee, L
Blatter, J
Mansouri, K
von Pawel, J
Citation: J. Vansteenkiste et al., Gemcitabine plus etoposide in chemonaive extensive disease small-cell lungcancer: A multi-centre phase II study, ANN ONCOL, 12(6), 2001, pp. 835-840
Authors:
Tjan-Heijnen, VCG
Postmus, PE
Ardizzoni, A
Manegold, C
Burghouts, J
van Meerbeeck, J
Gans, S
Mollers, M
Buchholz, E
Biesma, B
Legrand, C
Debruyne, C
Giaccone, G
Citation: Vcg. Tjan-heijnen et al., Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study, ANN ONCOL, 12(10), 2001, pp. 1359-1368
Authors:
Herth, F
Becker, HD
Manegold, C
Drings, P
Citation: F. Herth et al., Endobronchial ultrasound (EBUS) - Assessment of a new diagnostic tool in bronchoscopy for staging of lung cancer, ONKOLOGIE, 24(2), 2001, pp. 151-154
Citation: Mg. Kris et C. Manegold, Docetaxel (Taxotere) in the treatment of non-small cell lung cancer: An international update, SEMIN ONCOL, 28(1), 2001, pp. 1-3
Authors:
Georgoulias, V
Scagliotti, G
Miller, V
Eckardt, J
Douillard, JY
Manegold, C
Citation: V. Georgoulias et al., Challenging the platinum combinations: Docetaxel (Taxotere) combined with gemcitabine or vinorelbine in non-small cell lung cancer, SEMIN ONCOL, 28(1), 2001, pp. 15-21
Citation: M. Dietrich et al., Procalcitonin levels in severe Plasmodium falciparum malaria: Predictor ofoutcome or reflection of pathomechanisms? Reply, J INFEC DIS, 184(8), 2001, pp. 1091-1092
Authors:
Chiwakata, CB
Manegold, C
Bonicke, L
Waase, I
Julch, C
Dietrich, M
Citation: Cb. Chiwakata et al., Procalcitonin as a parameter of disease severity and risk of mortality in patients with Plasmodium falciparum malaria, J INFEC DIS, 183(7), 2001, pp. 1161-1164
Authors:
Manegold, C
Gatzemeier, U
von Pawel, J
Pirker, R
Malayeri, R
Blatter, J
Krejcy, K
Citation: C. Manegold et al., Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, Pemetrexed disodium, ALIMTA (TM)) and cisplatin: A multicenter phase II trial, ANN ONCOL, 11(4), 2000, pp. 435-440
Authors:
Sandler, AB
Nemunaitis, J
Denham, C
von Pawel, J
Cormier, Y
Gatzemeier, U
Mattson, K
Manegold, C
Palmer, MC
Gregor, A
Nguyen, B
Niyikiza, C
Einhorn, LH
Citation: Ab. Sandler et al., Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer, J CL ONCOL, 18(1), 2000, pp. 122-130
Authors:
Manegold, C
Krempe, C
Jablonowski, H
Kajala, L
Dietrich, M
Adams, O
Citation: C. Manegold et al., Comparative evaluation of two branched-DNA human immunodeficiency virus type 1 RNA quantification assays with lower detection limits of 50 and 500 copies per milliliter, J CLIN MICR, 38(2), 2000, pp. 914-917
Authors:
Mross, K
Scheulen, ME
Manegold, C
Westerhausen, M
Edler, L
Becher, R
Citation: K. Mross et al., Phase II study with interferon alpha-2a and 13-cis-retinoic acid in patients with metastatic renal cell carcinoma - A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society, ONKOLOGIE, 22(5), 1999, pp. 412-415
Authors:
Huinink, WWT
Bergman, B
Chemaissani, A
Dornoff, W
Drings, P
Kellokumpu-Lehtinen, PL
Liippo, K
Mattson, K
von Pawel, J
Ricci, S
Sederholm, C
Stahel, RA
Wagenius, G
von Walree, N
Manegold, C
Citation: Wwt. Huinink et al., Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer, LUNG CANC, 26(2), 1999, pp. 85-94
Citation: C. Manegold, Docetaxel (Taxotere) in non-small cell lung cancer: Ongoing studies in Heidelberg and future plans, SEMIN ONCOL, 26(3), 1999, pp. 23-27
Authors:
Paulli, M
Strater, J
Gianelli, U
Rousset, MT
Gambacorta, M
Orlandi, E
Klersy, C
Lavabre-Bertrand, T
Morra, E
Manegold, C
Lazzarino, M
Magrini, U
Moller, P
Citation: M. Paulli et al., Mediastinal B-cell lymphoma: A study of its histomorphologic spectrum based on 109 cases, HUMAN PATH, 30(2), 1999, pp. 178-187
Authors:
Rizzoli, R
Thiebaud, D
Bundred, N
Pecherstorfer, M
Herrmann, Z
Huss, HJ
Ruckert, F
Manegold, C
Tubiana-Hulin, M
Steinhauer, EU
Degardin, M
Thurlimann, B
Clemens, MR
Eghbali, H
Body, JJ
Citation: R. Rizzoli et al., Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy, J CLIN END, 84(10), 1999, pp. 3545-3550
Authors:
Manegold, C
Alwazzeh, M
Jablonowski, H
Adams, O
Medve, M
Seidlitz, B
Heidland, U
Haussinger, D
Strauer, BE
Heintzen, MP
Citation: C. Manegold et al., Prior cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary balloon angioplasty, CIRCULATION, 99(10), 1999, pp. 1290-1294
Authors:
van Meerbeeck, JP
Bass, P
Debruyne, C
Groen, HJ
Manegold, C
Ardizzoni, A
Gridelli, C
van Marck, EA
Lentz, M
Giaccone, G
Citation: Jp. Van Meerbeeck et al., A phase II study of gemcitabine in patients with malignant pleural mesothelioma, CANCER, 85(12), 1999, pp. 2577-2582